Gideon Pomeranz

The paper develops a low-cost method to create pre-vascularised scaffolds for organoid therapies, optimising parameters like porosity, lactide-to-glycolide ratio, and cell seeding density using PLGA and R-VECs.

The paper develops a nanobody-based method to label kidney lymphatic vessels in mice, revealing spatially restricted LYVE1 expression unique to the kidney.

This study shows vincristine treatment reduces podocyte damage in FSGS by preserving cytoskeletal structure and filtration barrier integrity.

The paper identifies a unique pericystic endothelium in ADPKD that contributes to microvascular remodelling and impaired perfusion, suggesting vascular targets for early intervention.

This study examines the phenotypic effects of SNX14 loss-of-function mutations in mice and zebrafish, revealing species-specific consequences despite conserved biochemical roles.